Is Varex Imaging Corp (VREX) overvalued? · rev $844.6M
Varex Imaging Corp (VREX) is a medical devices company listed on US.
This page asks whether Varex Imaging Corp (VREX) looks expensive on cached numbers — not a short thesis.
Latest reported VREX revenue for 2025-10-03 was $844.6M. Net income was -$69.9M. Revenue was up 4.1% from 2024-09-27 to 2025-10-03. VREX currently screens at market cap $350.0M.
VREX currently screens at market cap $350.0M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next VREX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the VREX stock page for the full model, not this heading.
Not investment advice.